These medications may have both positive and negative effects on the gastrointestinal tract
GLP-1 functions to stimulate the release of insulin (a hormone that lowers blood sugar) while suppressing the release of glucagon (a hormone that raises blood sugar) from the pancreas
Difference in gastrointestinal risk associated with use of GLP-1 receptor agonists: A real-world pharmacovigilance study
On Sunday, the reality star shared the photo, taken in the gym, with a close up of her face that showed a small bandage on her left cheek with the caption, "Happy Sunday." Most fans congratulated the "Keeping Up with the Kardashians" alum for her healthy glow, but others questioned what the bandage was for
As extensive as these metabolic changes were, and although they possess concordance with the functional and vascular changes previously demonstrated in our lab, they must be acknowledged to be preliminary and limited in their failure to display the full profile of ischemic myocardial GLP-1 agonism
Drug Effectiveness and Market Positioning Evaluation: Reviews oral obesity drugs by analyzing weight loss performance, safety concerns, tolerability, cardiometabolic profile, drug regimen, patient suitability and competition with injectables